ABCG2 and lung carcinoma: It has been shown, indeed, that Nrf2 silencing attenuates the expression of the ABCG2 transcript and protein and sensitises lung cancer cells to mitoxantrone and topotecan, two representative chemotherapeutic drugs effluxed mainly by the presence of ABCG2 [92].